Author

Ismail Taha Gürlek

Observed names: I.T. Gurlek, I.T. Gürlek, İsmail Taha Gürlek

Institution: Istanbul University

Observed institution: Istanbul University

ORCID: 0009-0001-6616-5022

Observed ORCID: 0009-0001-6616-5022

OpenAlex ID: A5120432666

Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review

2025 · Rifat Burak Ergül, Ismail Taha Gürlek, et al. · Pediatric Nephrology · 1

Automated kidney stone segmentation on computed tomography images using deep learning

2026 · R.B. Ergul, P. Dogan, et al. · European Urology Open Science

Pharmacovigilance analysis and real-world adverse event profile (safety signals and product-related issues) of potassium citrate: a US FDA adverse event reporting system (FAERS) based analysis

2026 · Rifat Burak Ergül, Ismail Taha Gürlek, et al. · Urolithiasis

Correlation of simultaneously monitored intrarenal and irrigation pressures during ureteroscopy: an in vivo pilot study

2026 · Ahmet Baris Aydin, Mehmet Guven Gunver, et al. · World Journal of Urology

Kidney Stone Segmentation from Computed Tomography Images Using Computer Vision Techniques

2026 · Rifat Burak Ergül, Poyraz Doğan, et al. · Research Square

Real-world adverse event profile of potassium citrate: Signal detection using the FDA adverse event reporting system (FAERS)

2025 · R.B. Ergül, I.T. Gürlek, et al. · European Urology Open Science

Real-world safety profile of Tiopronin: A pharmacovigilance study using the FDA adverse event reporting system (FAERS) by the EAU YAU Endourology and Urolithiasis Working Group

2025 · R.B. Ergül, I.T. Gürlek, et al. · European Urology Open Science

Works count: 7

Citation count: 1

H-index: 1

I10-index: